Generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.
The post All-stock deal: India’s Strides Arcolab to buy Shasun Pharma for $200 mn appeared first on Firstpost.